101,100 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 101,100 shares of the company’s stock, valued at approximately $2,346,000.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Option Care Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock worth $448,118,000 after purchasing an additional 75,313 shares during the period. Wellington Management Group LLP lifted its stake in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after acquiring an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock valued at $92,518,000 after acquiring an additional 591,042 shares in the last quarter. Norges Bank acquired a new position in shares of Option Care Health during the fourth quarter worth about $60,219,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after purchasing an additional 147,054 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Up 2.4 %

OPCH opened at $32.95 on Friday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a market cap of $5.41 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 2.30 and a beta of 1.07. The business’s fifty day moving average is $33.35 and its two-hundred day moving average is $28.83. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the firm earned $0.26 EPS. The business’s revenue for the quarter was up 16.3% compared to the same quarter last year. Analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on OPCH. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday. Finally, UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $38.00 to $40.00 in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.